Comments
Japan approves Novo's new combination insulin Ryzodeg
26.12.2012. | COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk said on Tuesday Japan's health regulator had approved its new combination insulin, that it plans to market as Ryzodeg, for the treatment of diabetes....